Margarida Duarte-Araújo Selected Research

Margarida Duarte-Araújo Research Topics

6	Inflammation (Inflammations) 12/2023 - 12/2011
5	Neoplasms (Cancer) 12/2023 - 05/2021
5	Cardiotoxicity 12/2023 - 05/2021
3	Fibrosis (Cirrhosis) 12/2023 - 11/2020
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 05/2021 - 11/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 10/2023
1	Multiple Sclerosis 05/2021
1	Necrosis 05/2021
1	Colitis 05/2021
1	COVID-19 11/2020
1	Edema (Dropsy) 04/2018
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 04/2018
1	Hyperthermia 01/2016

4	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2023 - 11/2021
3	Proteins (Proteins, Gene)FDA Link 12/2023 - 11/2020
3	AntioxidantsIBA 12/2023 - 11/2021
2	Glutathione Peroxidase GPX1IBA 12/2023 - 10/2023
2	Topoisomerase II InhibitorsIBA 10/2023 - 11/2021
2	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2023 - 05/2021
1	Peroxidase (Myeloperoxidase)IBA 12/2023
1	Type I Tumor Necrosis Factor ReceptorsIBA 10/2023
1	CatalaseIBA 10/2023
1	InterleukinsIBA 10/2023
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 10/2023
1	p38 Mitogen-Activated Protein KinasesIBA 10/2023
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2023
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 10/2023
1	ProdrugsIBA 01/2022
1	Acrolein (Aqualin)IBA 01/2022
1	4-hydroxycyclophosphamideIBA 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022
1	NF-kappa B (NF-kB)IBA 11/2021
1	Type II Tumor Necrosis Factor ReceptorsIBA 11/2021
1	Interleukin-6 (Interleukin 6)IBA 05/2021
1	Sulfonic AcidsIBA 05/2021
1	AcidsIBA 05/2021
1	sym-trinitrobenzeneIBA 05/2021
1	Angiotensin-Converting Enzyme 2IBA 11/2020
1	Tryptophan (L-Tryptophan)FDA Link 11/2020
1	IntegrinsIBA 11/2020
1	vedolizumabIBA 11/2020
1	Amino Acid Transport Systems (Amino Acid Transporter)IBA 11/2020
1	Glutathione Disulfide (GSSG)FDA LinkGeneric 04/2018
1	Methylphenidate (Ritalin)FDA LinkGeneric 04/2018
1	FibrinIBA 04/2018
1	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 01/2016
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 12/2011
1	Adenosine (Adenocard)FDA LinkGeneric 12/2011

1	Therapeutics 10/2023